Similarly, both TNFα and interleukin-1β (IL-1β) are expressed at low levels in normal breast epithelial cells, but are upregulated in the majority of breast cancer patients, with pronounced expression of both cytokines in over 80% of patients who experience breast tumor relapse (92). The gene discussed is TNF; the disease is breast neoplasm.